Overview

NO Prevention of COVID-19 for Healthcare Providers

Status:
Active, not recruiting
Trial end date:
2022-04-07
Target enrollment:
0
Participant gender:
All
Summary
Thousands of healthcare workers have been infected with SARS-CoV-2 and contracted COVID-19 despite their best efforts to prevent contamination. No proven vaccine is available to protect healthcare workers against SARS-CoV-2. This study will enroll 470 healthcare professionals dedicated to care for patients with proven SARS-CoV-2 infection. Subjects will be randomized either in the observational (control) group or in the inhaled nitric oxide group. All personnel will observe measures on strict precaution in accordance with WHO and the CDC regulations.
Phase:
Phase 2
Accepts Healthy Volunteers?
Accepts Healthy Volunteers
Details
Lead Sponsor:
Massachusetts General Hospital
Treatments:
Nitric Oxide
Criteria
Inclusion Criteria:

1. Age ≥18 years

2. Scheduled to work with SARS-CoV-2 infected patients for at least 3 days in a week.

Exclusion Criteria:

1. Previous documented SARS-CoV-2 infections and subsequent negative SARS-CoV-2 rt-PCR
test.

2. Pregnancy

3. Known hemoglobinopathies.

4. Known anemia